Exosomal mRNAs for Angiogenic–Osteogenic Coupled Bone Repair

• Published in: Advanced science Vol. 10; no. 33; pp. e2302622 - n/a
• Main Authors: Ma, Yifan, Sun, Lili, Zhang, Jingjing, Chiang, Chi‐ling, Pan, Junjie, Wang, Xinyu, Kwak, Kwang Joo, Li, Hong, Zhao, Renliang, Rima, Xilal Y., Zhang, Chi, Zhang, Anan, Liu, Yutong, He, Zirui, Hansford, Derek, Reategui, Eduardo, Liu, Changsheng, Lee, Andrew S., Yuan, Yuan, Lee, Ly James
• Format: Journal Article
• Language: English
• Published: Weinheim John Wiley & Sons, Inc 01.11.2023; Wiley
• Subjects: bone morphogenetic protein 2 (BMP‐2) mRNAs coupled angiogenic–osteogenic regeneration; Bone surgery; Bones; Cells; Chromatography; Coronaviruses; COVID-19; Disease transmission; Efficiency; Extracellular vesicles; Gene therapy; Microelectromechanical systems; MicroRNAs; PEGylated poly (glycerol sebacate) acrylate (PEGS‐A) hydrogel; Plasmids; small extracellular vesicles carrying therapeutic mRNAs and associated microRNAs; Tissue engineering; track‐etched membrane‐based nanoelectroporation (TM‐nanoEP); Vascular endothelial growth factor; vascular endothelial growth factor A (VEGF‐A)
• ISSN: 2198-3844; 2198-3844
• DOI: 10.1002/advs.202302622

Regenerative medicine in tissue engineering often relies on stem cells and specific growth factors at a supraphysiological dose. These approaches are costly and may cause severe side effects. Herein, therapeutic small extracellular vesicles (t‐sEVs) endogenously loaded with a cocktail of human vascular endothelial growth factor A (VEGF‐A) and human bone morphogenetic protein 2 (BMP‐2) mRNAs within a customized injectable PEGylated poly (glycerol sebacate) acrylate (PEGS‐A) hydrogel for bone regeneration in rats with challenging femur critical‐size defects are introduced. Abundant t‐sEVs are produced by a facile cellular nanoelectroporation system based on a commercially available track‐etched membrane (TM‐nanoEP) to deliver plasmid DNAs to human adipose‐derived mesenchymal stem cells (hAdMSCs). Upregulated microRNAs associated with the therapeutic mRNAs are enriched in t‐sEVs for enhanced angiogenic–osteogenic regeneration. Localized and controlled release of t‐sEVs within the PEGS‐A hydrogel leads to the retention of therapeutics in the defect site for highly efficient bone regeneration with minimal low accumulation in other organs. This study describes an easily scalable and cost‐effective method to produce abundant therapeutic small extracellular vesicles (t‐sEVs) carrying a cocktail of functional mRNAs (VEGF‐A and BMP‐2) within a customized injectable PEGylated poly (glycerol sebacate) acrylate (PEGS‐A) hydrogel cage for coupling bone regeneration in rats that have challenging femur critical‐size defects.